Induction of oxidative stress by the metabolites accumulating in isovaleric acidemia in brain cortex of young rats

References

• Tanaka K, Budd MA, Efron ML, Isselbacher KJ. Isovaleric acidemia: A new genetic defect of leucine metabolism. Proc Natl Acad Sci USA 1966; 56: 236–242
   PubMed Web of Science ®Google Scholar
• Sweetman L, Williams JC. Disorders of branched-chain amino acid and organic acid metabolism. The metabolic and molecular bases of inherited disease, CR Scriver, AL Beaudet, WS Sly, D Valle. McGraw Hill, New York 2001; 2125–2159
   Google Scholar
• Lin WD, Wang CH, Lee CC, Lai CC, Tsai Y, Tsai FJ. Genetic mutation profile of isovaleric acidemia patients in Taiwan. Molec Genet Metab 2007; 90: 134–139
   Google Scholar
• Lee YW, Lee DH, Vockley J, Kim ND, Lee YK, Ki CS. Different spetrum of mutations of isovaleryl-CoA dehydrogenase (IVD) gene in Korean patients with isovaleric acidemia. Molec Genet Metab 2007; 92: 71–77
   Google Scholar
• Ribeiro CAJ, Balestro F, Grando V, Wajner M. Isovaleric acid reduces N+, K + -ATPase activity in synaptic membranes from cerebral cortex of young rats. Cell Molec Neurobiol 2007; 27: 529–540
   Google Scholar
• Tanaka K, Isselbacher KJ. The isolation and identification of N-isovalerilglicine from urine of patients whith isovaleric acidemia. J Biol Chem 1967; 242: 2966–2972
   PubMed Web of Science ®Google Scholar
• Tanaka K, Nest-Dull A, Hine DG, Lynn TB, Lone T. Gaschromatographic method of analysis for urinary organic acids. II- Description of the procedure, and its application to diagnosis of patients with organic acidurias. Clin Chem 1980; 26: 1847–1853
   Google Scholar
• Schulze A, Lindner M, Kohlmüller D, Olgemöller K, Mayatepek E, Hoffmann GF. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 2003; 111: 1399–1406
   PubMed Web of Science ®Google Scholar
• Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, Strauss AW, Comeau AM, Eaton RB, Grady GF. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 2001; 47: 1945–1955
   PubMed Web of Science ®Google Scholar
• Chase DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 2003; 49: 1797–1817
   Google Scholar
• Ensenauer R, Vockley J, Willard J-M, Huey JC, Sass JO, Edland SD, Burton BK, Berry SA, Santer R, Grünert S, Koch H-G, Marquadt I, Rinaldo P, Hahn S, Matern D. A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Human Genet 2004; 75: 1136–1142
   PubMed Web of Science ®Google Scholar
• Sogut A, Acun C, Aydin K, Tomsac N, Demirel F, Aktuglu C. Isovaleric acidaemia: cranial CT and MRI findings. Pediatric Radiol 2004; 34: 160–162
   Google Scholar
• Leipnitz G, Seminotti B, Amaral AU, de Bortoli G, Solano A, Schuck PF, Wyse ATS, Wannmacher CMD, Latini A, Wajner M. Induction of oxidative stress by the metabolites accumulating in 3-methylglutaconic aciduria in cerebral cortex of young rats. Life Sci 2008; 82: 652–662
   PubMed Web of Science ®Google Scholar
• Evelson P, Travacio M, Repetto M, Escobar J, Llesuy S, Lissi E. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys 2001; 388: 261–266
   PubMed Web of Science ®Google Scholar
• Cassina A, Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996; 328: 309–316
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407–421
   PubMed Web of Science ®Google Scholar
• Gonzalez-Flecha B, Llesuy S, Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 1991; 10: 93–100
   PubMed Web of Science ®Google Scholar
• Browne RW, Armstrong D. Reduced glutathione and glutathione disulfide. Methods Molec Biol 1998; 108: 347–352
   PubMedGoogle Scholar
• Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994; 233: 357–363
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Tanaka K. Isovaleric acidemia: personal history, clinical survey and study of the molecular basis. Prog Clin Biol Res 1990; 321: 273–290
   Google Scholar
• Vockley J, Ensenauer R. Isovaleric acidemia: new aspects of genetic and phenotipic heterogeneity. Am J Med Genet 2006; 142C: 95–103
   Google Scholar
• Halliwell B, Gutteridge JMC. Measurement of reactive species. Free radicals in biology and medicine4th ed, B Halliwell, JMC Gutteridge. Oxford University Press, Oxford 2007; 268–340
   Google Scholar
• Dalle-Done I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003; 329: 23–38
   PubMed Web of Science ®Google Scholar
• Levine RL. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 2002; 32: 790–796
   PubMed Web of Science ®Google Scholar
• Reznick AZ, Packer L. Free radicals and antioxidants in muscular neurological diseases and disorders. Free radicals: from basic science to medicine, G Poli, E Albano, UM Dianzani. Birkhauser Verlag, Basel 1993; 425–437
   Google Scholar
• Halliwell B, Gutteridge JMC. Oxygen radicals and nervous system. Trends Neurosci 1996; 8: 22–26
   Google Scholar
• Perez-Severiano F, Rios C, Segovia J. Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease. Brain Res 2000; 862: 234–237
   PubMed Web of Science ®Google Scholar
• Bogdanov MB, Andreassen OA, Dedeoglu A, Ferrante RJ, Beal MF. Increased oxidative damage to DNA in a transgenic mouse of Huntington's disease. J Neurochem 2001; 79: 1246–1249
   PubMed Web of Science ®Google Scholar
• Méndez-Álvarez E, Soto-Otero R, Hermida-Aeijeiras A, López-Real AM, Labandeira-García JL. Effects of aluminium and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease. Biochim Biophys Acta 2001; 1586: 155–168
   Google Scholar
• Karelson E, Bogdanovic N, Garlind A, Winblad B, Zilmer K, Kullisaar T, Vihalemm T, Kairane C, Zilmer M. The cerebrocortical areas in normal brain aging and in the Alzheimer's disease: noticeable difference in the lipid peroxidation level and in antioxidant defense. Neurochem Res 2001; 26: 353–361
   PubMed Web of Science ®Google Scholar
• Behl C, Moosmann B. Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds. Biol Chem 2002; 383: 521–536
   PubMed Web of Science ®Google Scholar
• Stoy N, Mackay GM, Forrest CM, Christofides J, Egerton M, Stone TW, Darlington LG. Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J Neurochem 2005; 93: 611–623
   PubMed Web of Science ®Google Scholar
• Berg D, Youdim MB. Role of iron in neurodegenerative disorders. Topics Magn Resonance Imaging 2006; 17: 5–17
   PubMedGoogle Scholar
• Mancuso M, Coppede F, Migliore L, Siciliano G, Murri L. Mitochondrial dysfunction, oxidative stress and neurodegeneration. J Alzheimer's Dis 2006; 10: 59–73
   PubMed Web of Science ®Google Scholar